Sensex Today | Morgan Stanley retains ‘overweight’ rating on Lupin, target price at Rs 2,096
#1 Q2 revenue beat estimates led by strong US & EM sales
#2 Gross margin up 390 bps YoY to 74 percent, driven by high-value generics gJynarque & gSpiriva
#3 EBITDA grew 75 percent YoY with record 33 percent margin
Lupin was quoting at Rs 1,976.75, up Rs 20.70, or 1.06 percent.
It has touched an intraday high of Rs 2,001.75 and an intraday low of Rs 1,960.85.
It was trading with volumes of 128,826 shares, compared to its five day average of 30,570 shares, an increase of 321.42 percent.
In the previous trading session, the share closed down 2.11 percent or Rs 42.10 at Rs 1,956.05.
The share touched a 52-week high of Rs 2,403.45 and a 52-week low of Rs 1,774.00 on 02 January, 2025 and 07 April, 2025, respectively.
Currently, the stock is trading 17.75 percent below its 52-week high and 11.43 percent above its 52-week low.
Market capitalisation stands at Rs 90,290.46 crore.
